Susan Veldhof

5.9k citations

61 papers · 4.2k indexed · 3 hit papers · h-index 32

Surgery top 0.5%
Cardiology and Cardiovascular Medicine top 0.5%
Pulmonary and Respiratory Medicine top 1%
Radiology, Nuclear Medicine and Imaging top 1%
Biomedical Engineering top 10%

Co-authors: Patrick W. Serruys Yoshinobu Onuma Dariusz Dudek Héctor M. García‐García Leif Thuesen John A. Ormiston Evelyn Regar Cécile Dorange
Topics: Coronary Interventions and Diagnostics (60 papers)Cardiac Imaging and Diagnostics (29 papers)Cardiac Valve Diseases and Treatments (22 papers)
Cited by: Cardiology and Cardiovascular Medicine Surgery Radiology, Nuclear Medicine and Imaging
Journals: The Lancet Circulation Journal of the American College of Cardiology
Partner nations: Netherlands United States New Zealand

In The Last Decade

Susan Veldhof

59 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods

2009 584 citations Patrick W. Serruys, John A. Ormiston et al. profile →
A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

2008 496 citations John A. Ormiston, Patrick W. Serruys et al. profile →
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial

2014 393 citations Patrick W. Serruys, Bernard Chevalier et al. profile →

Peers

Countries citing papers authored by Susan Veldhof

Since Specialization

Citations

This map shows the geographic impact of Susan Veldhof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Veldhof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Veldhof more than expected).

Fields of papers citing papers by Susan Veldhof

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Veldhof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Veldhof. The network helps show where Susan Veldhof may publish in the future.

Co-authorship network of co-authors of Susan Veldhof

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Veldhof. A scholar is included among the top collaborators of Susan Veldhof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Veldhof. Susan Veldhof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Vasomotor Response to Nitroglycerine Over 5 Years Follow-Up After Everolimus-Eluting Bioresorbable Scaffold Implantation 2017 ·JACC: Cardiovascular Interventions ·Dariusz Dudek,Łukasz Rzeszutko,Yoshinobu Onuma,Yohei Sotomi,(unknown),Susan Veldhof,Divine Ediebah,Peter Stæhr,Wojciech Zasada,Krzysztof Piotr Malinowski,Grzegorz L. Kałuża,Patrick W. Serruys	19
2	Efficacy and Safety of the Absorb Everolimus-Eluting Bioresorbable Scaffold for Treatment of Patients With Diabetes Mellitus 2016 ·JACC: Cardiovascular Interventions ·Dean J. Kereiakes,Stephen G. Ellis,Takeshi Kimura,Alexandre Abizaid,Weiying Zhao,Susan Veldhof,(unknown),Zhen Zhang,Yoshinobu Onuma,Bernard Chevalier,Patrick W. Serruys,Gregg W. Stone	20
3	A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis 2016 ·Journal of the American College of Cardiology ·Patrick W. Serruys,John Ormiston,Robert‐Jan van Geuns,Bernard De Bruyne,Dariusz Dudek,Evald Høj Christiansen,Bernard Chevalier,Pieter Smits,Dougal McClean,Jacques Koolen,Stephan Windecker,Robert Whitbourn,Ian T. Meredith,Luc Wasungu,Divine Ediebah,Susan Veldhof,Yoshinobu Onuma	119
4	Relation Between Bioresorbable Scaffold Sizing Using QCA-Dmax and Clinical Outcomes at 1 Year in 1,232 Patients From 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II) 2015 ·JACC: Cardiovascular Interventions ·Yuki Ishibashi,Shimpei Nakatani,Yohei Sotomi,Pannipa Suwannasom,Maik J. Grundeken,Héctor M. García‐García,Antonio L. Bartorelli,Robert Whitbourn,Bernard Chevalier,Alexandre Abizaid,John A. Ormiston,Richard Rapoza,Susan Veldhof,Yoshinobu Onuma,Patrick W. Serruys	42
5	Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data 2015 ·EuroIntervention ·Christos V. Bourantas,Patrick W. Serruys,Shimpei Nakatani,Yao‐Jun Zhang,Vasim Farooq,Roberto Diletti,(unknown),Alexander Sheehy,Robert‐Jan van Geuns,Dougal McClean,Bernard Chevalier,Stephan Windecker,Jacques Koolen,John A. Ormiston,Robert Whitbourn,Richard Rapoza,Susan Veldhof,Yoshinobu Onuma,Héctor M. García‐García	36
6	Incidence and Imaging Outcomes of Acute Scaffold Disruption and Late Structural Discontinuity After Implantation of the Absorb Everolimus-Eluting Fully Bioresorbable Vascular Scaffold 2014 ·JACC: Cardiovascular Interventions ·Yoshinobu Onuma,Patrick W. Serruys,Takashi Muramatsu,Shimpei Nakatani,Robert‐Jan van Geuns,Bernard De Bruyne,Dariusz Dudek,Evald Høj Christiansen,Pieter C. Smits,Bernard Chevalier,Dougal McClean,Jacques Koolen,Stephan Windecker,Robert Whitbourn,Ian T. Meredith,Héctor M. García‐García,Susan Veldhof,Richard Rapoza,John A. Ormiston	87
7	1-Year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds 2014 ·JACC: Cardiovascular Interventions ·Takashi Muramatsu,Yoshinobu Onuma,Robert‐Jan van Geuns,Bernard Chevalier,Tejas Patel,Ashok Seth,Roberto Diletti,Héctor M. García‐García,Cécile Dorange,Susan Veldhof,Wai-Fung Cheong,Yukio Ozaki,Robert Whitbourn,Antonio L. Bartorelli,Gregg W. Stone,Alexandre Abizaid,Patrick W. Serruys	33
8	Scaffold and Edge Vascular Response Following Implantation of Everolimus-Eluting Bioresorbable Vascular Scaffold 2014 ·JACC: Cardiovascular Interventions ·Yao‐Jun Zhang,Javaid Iqbal,Shimpei Nakatani,Christos V. Bourantas,Carlos M. Campos,Yuki Ishibashi,Yun‐Kyeong Cho,Susan Veldhof,Jin Wang,Yoshinobu Onuma,Héctor M. García‐García,Dariusz Dudek,Robert‐Jan van Geuns,Patrick W. Serruys	15
9	TCT-245 Diabetic patients treated with Bioresorbable Vascular Scaffolds show good clinical outcomes at two-year follow-up: A pooled analysis from the ABSORB and SPIRIT trials 2014 ·Journal of the American College of Cardiology ·Javaid Iqbal,Yoshinobu Onuma,Robert J. Van Geuns,Bernard Chevalier,Takashi Muramatsu,Yao‐Jun Zhang,Susan Veldhof,Pieter C. Smits,Robert Whitbourn,Antonio L. Bartorelli,Gregg W. Stone,Alexandre Abizaid,Patrick W. Serruys	1
10	Incidence and Short-Term Clinical Outcomes of Small Side Branch Occlusion After Implantation of an Everolimus-Eluting Bioresorbable Vascular Scaffold 2013 ·JACC: Cardiovascular Interventions ·Takashi Muramatsu,Yoshinobu Onuma,Héctor M. García‐García,Vasim Farooq,Christos V. Bourantas,Marie-angèle Morel,(unknown),Susan Veldhof,Antonio L. Bartorelli,Robert Whitbourn,Alexandre Abizaid,Patrick W. Serruys	77
11	Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study 2012 ·EuroIntervention ·Josep Gómez‐Lara,Roberto Diletti,Salvatore Brugaletta,Yoshinobu Onuma,Vasim Farooq,Leif Thuesen,Dougal McClean,Jacques Koolen,John A. Ormiston,Stefan Windecker,Robert Whitbourn,Dariusz Dudek,Cécile Dorange,Susan Veldhof,Richard Rapoza,Evelyn Regar,Héctor M. García‐García,Patrick W. Serruys	35
12	VASCULAR COMPLIANCE CHANGES OF THE CORONARY VESSEL WALL AFTER BIORESORBABLE VASCULAR SCAFFOLD IMPLANTATION IN THE TREATED AND ADJACENT SEGMENTS 2012 ·Journal of the American College of Cardiology ·Salvatore Brugaletta,Bill D. Gogas,Héctor M. García‐García,Vasim Farooq,Chrysafios Girasis,(unknown),(unknown),(unknown),(unknown),Jacques Koolen,Pieter C. Smits,Susan Veldhof,Richard Rapoza,Yoshinobu Onuma,John A. Ormiston,Patrick W. Serruys	1
13	Head-to-Head Comparison of the Neointimal Response Between Metallic and Bioresorbable Everolimus-Eluting Scaffolds Using Optical Coherence Tomography 2011 ·JACC: Cardiovascular Interventions ·Josep Gómez‐Lara,Salvatore Brugaletta,Vasim Farooq,Yoshinobu Onuma,Roberto Diletti,Stephan Windecker,Leif Thuesen,Dougal McClean,Jacques Koolen,Robert Whitbourn,Dariusz Dudek,Pieter C. Smits,Bernard Chevalier,Evelyn Regar,Susan Veldhof,Richard Rapoza,John A. Ormiston,Héctor M. García‐García,Patrick W. Serruys	51
14	Serial Analysis of the Malapposed and Uncovered Struts of the New Generation of Everolimus-Eluting Bioresorbable Scaffold With Optical Coherence Tomography 2011 ·JACC: Cardiovascular Interventions ·Josep Gómez‐Lara,Maria Radu,Salvatore Brugaletta,Vasim Farooq,Roberto Diletti,Yoshinobu Onuma,Stephan Windecker,Leif Thuesen,Dougal McClean,Jacques Koolen,Robert Whitbourn,Dariusz Dudek,Pieter C. Smits,Evelyn Regar,Susan Veldhof,Richard Rapoza,John A. Ormiston,Héctor M. García‐García,Patrick W. Serruys	65
15	Monitoring In Vivo Absorption of a Drug-Eluting Bioabsorbable Stent With Intravascular Ultrasound-Derived Parameters 2010 ·JACC: Cardiovascular Interventions ·Nico Bruining,Sebastiaan de Winter,Jos R.T.C. Roelandt,Evelyn Regar,Iddo Heller,Ron T. van Domburg,Ronald Hamers,Yoshinobu Onuma,Darius Dudek,Mark Webster,Leif Thuesen,John A. Ormiston,Wai‐Fung Cheong,Karine Miquel‐Hébert,Susan Veldhof,Patrick W. Serruys	30
16	Clinical Follow-Up 3 Years After Everolimus- and Paclitaxel-Eluting Stents 2010 ·JACC: Cardiovascular Interventions ·Adriano Caixeta,Alexandra J. Lansky,Patrick W. Serruys,James Hermiller,Peter Ruygrok,Yoshinobu Onuma,Paul Gordon,Manejeh Yaqub,Karine Miquel‐Hébert,Susan Veldhof,Poornima Sood,Xiaolu Su,(unknown),Krishnankutty Sudhir,Gregg W. Stone	37
17	3-Year Clinical Follow-Up of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With De Novo Coronary Artery Lesions 2009 ·JACC: Cardiovascular Interventions ·Scot Garg,Patrick W. Serruys,Yoshinobu Onuma,Cécile Dorange,Susan Veldhof,Karine Miquel‐Hébert,Krishnankutty Sudhir,Jean Boland,Kurt Huber,Eulogio Garcı́a,(unknown)	78
18	Two-year results of a durable polymer everolimus-eluting stent in de novo coronary artery stenosis (The SPIRIT FIRST Trial) 2007 ·EuroIntervention ·Marcel A.M. Beijk,Franz–Josef Neumann,Marcus Wiemer,Eberhard Grube,Jürgen Haase,Leif Thuesen,Christian W. Hamm,Susan Veldhof,Cécile Dorange,Patrick Serruys,Jan J. Piek	28
19	The FRONTIER Stent Registry 2005 ·Journal of the American College of Cardiology ·Thierry Lefèvre,John A. Ormiston,Giulio Guagliumi,Heinz‐Peter Schultheiss,Laurent Quilliet,Bernhard Reimers,Philippe Brunel,William Wijns,H. J. Buettner,Franz Hartmann,Susan Veldhof,(unknown),Xiaolu Su,Willem J. van der Giessen	57
20	Direct Stenting Versus Direct Stenting Followed by Centered Beta-Radiation With Intravascular Ultrasound-Guided Dosimetry and Long-Term Anti-Platelet Treatment 2004 ·Journal of the American College of Cardiology ·Patrick W. Serruys,William Wijns,Georgios Sianos,Ivan De Scheerder,(unknown),Wolfgang Rutsch,Helmut D. Glogar,Carlos Macaya,Pierre Materne,Susan Veldhof,(unknown),(unknown),Wim J. van der Giessen	20

About Susan Veldhof

Susan Veldhof is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging, having authored 61 papers that have together received 4.2k indexed citations. Recurring topics across this work include Coronary Interventions and Diagnostics (60 papers), Cardiac Imaging and Diagnostics (29 papers) and Cardiac Valve Diseases and Treatments (22 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (2.4k citations), Surgery (3.9k citations) and Radiology, Nuclear Medicine and Imaging (1.2k citations). Susan Veldhof has collaborated with scholars based in Netherlands, United States and New Zealand. Frequent co-authors include Patrick W. Serruys, Yoshinobu Onuma, Dariusz Dudek, Héctor M. García‐García, Leif Thuesen, John A. Ormiston, Evelyn Regar, Cécile Dorange, Mark Webster and Bernard Chevalier. Their work appears in journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact